Put Options

24 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$57.33 - $68.61 $57,330 - $68,610
1,000 Added 8.06%
13,400 $885,000
Q2 2024

Aug 14, 2024

SELL
$51.18 - $63.75 $214,956 - $267,750
-4,200 Reduced 25.3%
12,400 $751,000
Q1 2024

May 15, 2024

SELL
$56.55 - $66.59 $458,055 - $539,379
-8,100 Reduced 32.79%
16,600 $945,000
Q4 2023

Feb 14, 2024

BUY
$52.16 - $64.19 $1.05 Million - $1.3 Million
20,200 Added 448.89%
24,700 $1.55 Million
Q3 2023

Nov 14, 2023

BUY
$57.77 - $65.93 $98,209 - $112,081
1,700 Added 60.71%
4,500 $259,000
Q2 2023

Aug 14, 2023

BUY
$60.95 - $75.51 $24,380 - $30,204
400 Added 16.67%
2,800 $174,000
Q1 2023

May 15, 2023

SELL
$70.23 - $86.01 $765,507 - $937,509
-10,900 Reduced 81.95%
2,400 $173,000
Q4 2022

Feb 14, 2023

BUY
$67.18 - $84.11 $893,494 - $1.12 Million
13,300 New
13,300 $1.07 Million
Q1 2022

May 16, 2022

BUY
$66.02 - $79.71 $3.55 Million - $4.28 Million
53,700 Added 466.96%
65,200 $5.18 Million
Q4 2021

Feb 14, 2022

SELL
$63.34 - $74.11 $107,678 - $125,987
-1,700 Reduced 12.88%
11,500 $844,000
Q3 2021

Nov 15, 2021

BUY
$68.67 - $84.02 $810,306 - $991,436
11,800 Added 842.86%
13,200 $908,000
Q2 2021

Aug 16, 2021

BUY
$79.87 - $87.53 $55,909 - $61,271
700 Added 100.0%
1,400 $118,000
Q1 2021

May 17, 2021

SELL
$76.02 - $100.5 $212,856 - $281,400
-2,800 Reduced 80.0%
700 $57,000
Q4 2020

Feb 16, 2021

BUY
$80.74 - $97.7 $72,666 - $87,930
900 Added 34.62%
3,500 $304,000
Q3 2020

Nov 16, 2020

SELL
$85.07 - $109.69 $25,520 - $32,907
-300 Reduced 10.34%
2,600 $233,000
Q2 2020

Aug 14, 2020

SELL
$74.18 - $108.93 $667,620 - $980,370
-9,000 Reduced 75.63%
2,900 $302,000
Q1 2020

May 15, 2020

SELL
$63.18 - $85.97 $322,218 - $438,447
-5,100 Reduced 30.0%
11,900 $871,000
Q4 2019

Feb 14, 2020

SELL
$73.04 - $95.72 $284,856 - $373,308
-3,900 Reduced 18.66%
17,000 $1.48 Million
Q3 2019

Nov 14, 2019

BUY
$72.82 - $86.52 $1.06 Million - $1.26 Million
14,600 Added 231.75%
20,900 $1.55 Million
Q2 2019

Aug 14, 2019

SELL
$73.52 - $88.7 $1.46 Million - $1.77 Million
-19,900 Reduced 75.95%
6,300 $535,000
Q1 2019

May 15, 2019

BUY
$63.56 - $88.17 $1.23 Million - $1.7 Million
19,300 Added 279.71%
26,200 $2.25 Million
Q4 2018

Feb 14, 2019

SELL
$58.5 - $69.94 $1.13 Million - $1.36 Million
-19,400 Reduced 73.76%
6,900 $439,000
Q3 2018

Nov 14, 2018

BUY
$61.75 - $74.23 $1.44 Million - $1.73 Million
23,300 Added 776.67%
26,300 $1.82 Million
Q2 2018

Aug 14, 2018

BUY
$60.85 - $83.98 $182,550 - $251,940
3,000 New
3,000 $201,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.